Latest Nxstage Medical (NXTM) Headlines
Uptrend Call Working As NxStage Medical Stock Rises 21.8% (NXTM)
Comtex SmarTrend(R) - Wed Mar 12, 11:06AM CDT
SmarTrend identified an Uptrend for NxStage Medical (NASDAQ:NXTM) on January 9th, 2014 at $11.37. In approximately 2 months, NxStage Medical has returned 21.81% as of today's recent price of $13.85.
Downgrade Alert for NxStage Medical (NXTM)
Comtex SmarTrend(R) - Tue Mar 11, 6:58AM CDT
NxStage Medical (NASDAQ:NXTM) was downgraded from Market Perform to Underperform at Wells Fargo today. The stock closed yesterday at $14.66 on volume of 1.3 million shares, above average daily volume of 497,000. In the past 52 weeks, NxStage Medical share prices have been bracketed by a low of $8.77 and a high of $15.00 and closed yesterday at $14.66, 67% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 2.2% while the 200-day MA has remained constant.
US Market for Dialysis Equipment and Concentrates
M2 - Thu Mar 06, 3:09AM CST
Research and Markets (http://www.researchandmarkets.com/research/npv4t6/u_s_market_for) has announced the addition of the "U.S. Market for Dialysis Equipment and Concentrates" report to their offering. The Total Dialysis Device And Concentrates Market Will Grow To A Value Of Almost $2 Billion By 2020 The total dialysis device and concentrates market includes the markets for hemodialysis machines, dialysis catheters, dialysis concentrates, dialyzers, dialyzer reprocessing machines, bloodlines, AV fistula needles, AV grafts, declotting devices, guidewires, introducer sheaths and water treatment systems. The market will grow as a result of increased patient populations. The patient populations of traditional incenter hemodialysis, home hemodialysis (HHD) and peritoneal dialysis are expected to grow over the forecast period. There will also be strong growth in the dry concentrates and heat disinfectant water treatment system market. Scope of the Report - Competitor Analysis - Identified Strategic Opportunities - Market Overview by Segment - Trend Analysis by Segment - Market Drivers & Limiters - Mergers & Acquisitions - Customer Feedback & Market Monitoring Reasons To Buy This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on a 'ground up' approach, which includes primary and secondary research methods. This report forecasts the development of the US market up to 2020. Key Topics Covered - Executive Summary - Research Methodology - US Dialysis Device And Concentrates Market - Hemodialysis Machine Market - Dialysis Catheter Market - Dialysis Concentrates Market - Dialyzer Market - Dialyzer Reprocessing Machine Market - Hemodialysis Bloodline And Tubing Set Market - Av Fistula Needle Market - Av Access Graft Market - Declotting Device Market - Introducer Sheath And Guidewire Market - Water Treatment System Market Companies Mentioned - AmeriWater - AngioDynamics - Argon Medical - Asahi Kasei Medical - B. Braun - Baxter - C. R. Bard - Cook Medical - Cordis - Covidien - Edwards Lifesciences - Fresenius - Gambro - Kawasumi Laboratories - LeMaitre - MAKY - MEDRAD - Mar Cor - Medcomp - Medisystems (NxStage Medical) - Medivators - NxStage Medical - Rockwell - Teleflex Medical - Terumo, - Vascular - W. L. Gore For more information visit http://www.researchandmarkets.com/research/np...market_for About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
Shares of NXTM Up 25.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Mar 05, 9:41AM CST
SmarTrend identified an Uptrend for NxStage Medical (NASDAQ:NXTM) on January 9th, 2014 at $11.37. In approximately 2 months, NxStage Medical has returned 25.95% as of today's recent price of $14.32.
U.S. Market for Dialysis Equipment and Concentrates (Executive Summary)
M2 - Fri Feb 28, 10:28AM CST
Research and Markets (http://www.researchandmarkets.com/research/cbwzlh/u_s_market_for) has announced the addition of the U.S. Market for Dialysis Equipment and Concentrates (Executive Summary) report to their offering. This executive summary relates to the report U.S. Market for Dialysis Equipment and Concentrates. The total dialysis device and concentrates market will grow to a value of almost $2 billion over the forecast period. The total dialysis device and concentrates market includes the markets for hemodialysis machines, dialysis catheters, dialysis concentrates, dialyzers, dialyzer reprocessing machines, bloodlines, AV fistula needles, AV grafts, declotting devices, guidewires, introducer sheaths and water treatment systems. The market will grow as a result of increased patient populations. The patient populations of traditional incenter hemodialysis, home hemodialysis (HHD) and peritoneal dialysis are expected to grow over the forecast period. There will also be strong growth in the dry concentrates and heat disinfectant water treatment system market. This report pertains to a forecast period of 10 years (2010 - 2020) for the U.S. market. Scope of the Report - Competitor Analysis - Identified Strategic Opportunities - Market Overview by Segment - Trend Analysis by Segment - Market Drivers & Limiters - Mergers & Acquisitions - Customer Feedback & Market Monitoring Main Segments Included - U.S. Dialysis Device and Concentrates Market - Hemodialysis Machine Market - Dialysis Catheter Market - Dialysis Concentrates Market - Dialyzer Market - Dialyzer Reprocessing Machine Market - Hemodialysis Bloodline and Tubing Set Market - AV Fistula Needle Market - AV Access Graft Market - Declotting Device Market - Introducer Sheath and Guidewire Market - Water Treatment System Market Reasons To Buy This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on a 'ground up' approach, which includes primary and secondary research methods. * Please note this is an executive summary only. The full report is available for purchase by following the link below. Key Topics Covered: 1. Executive Summary 1.1 U.S. Dialysis Device And Concentrates Market 1.2 Hemodialysis Machine Market 1.3 Dialysis Catheter Market 1.4 Dialysis Concentrates Market 1.5 Dialyzer Market 1.6 Dialyzer Reprocessing Machine Market 1.7 Hemodialysis Bloodline And Tubing Set Market 1.8 Av Fistula Needle Market 1.9 Av Access Graft Market 1.10 Declotting Device Market 1.11 Introducer Sheath And Guidewire Market 1.12 Water Treatment System Market 1.13 Competitive Analysis Companies Mentioned: - AmeriWater - AngioDynamics - Argon Medical - Asahi Kasei Medical - B. Braun - Baxter - C. R. Bard - Cook Medical - Cordis - Covidien - Edwards Lifesciences - Fresenius - Gambro - Kawasumi Laboratories - LeMaitre - MAKY - MEDRAD - Mar Cor - Medcomp - Medisystems (NxStage Medical) - Medivators - NxStage Medical - Rockwell - Teleflex Medical - Terumo, - Vascular - W. L. Gore For more information visit http://www.researchandmarkets.com/research/cb...market_for About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
NxStage Reports Record Fourth Quarter and Full-Year 2013 Financial Results
PR Newswire - Thu Feb 27, 6:31AM CST
NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today reported record financial results for the three and twelve months ended December 31, 2013, that include revenue slightly above its recent guidance.
NxStage Medical Up 20.2% Since SmarTrend Uptrend Call (NXTM)
Comtex SmarTrend(R) - Wed Feb 26, 9:18AM CST
SmarTrend identified an Uptrend for NxStage Medical (NASDAQ:NXTM) on January 9th, 2014 at $11.37. In approximately 2 months, NxStage Medical has returned 20.23% as of today's recent price of $13.67.
BrainStorm Receives Additional $600,000 Non-Dilutive Grant From Israel's Office of the Chief Scientist
Marketwire - Tue Feb 25, 8:15AM CST
BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that BrainStorm Cell Therapeutics Ltd. was awarded an additional non-dilutive grant from Israel's Office of the Chief Scientist (OCS) for the year 2014 in the amount of $600,000. The grant is intended to support BrainStorm's clinical development for its innovative stem cell therapy candidate NurOwn(TM).
Former NxStage Patient Celebrates Life Milestones
PR Newswire - Mon Feb 24, 7:00AM CST
NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, is proud to celebrate with former patient Laurie and her husband/care partner Mike two significant life milestones: their 30 year wedding anniversary and Laurie's second kidney transplant. For the couple, more frequent home hemodialysis (HHD) with the NxStage® System One(TM) proved to be a good personal fit for them. The convenience and flexibility of the therapy not only helped them stay focused on their lifestyle, but also gave them the opportunity to focus their collective energy on finding a second kidney donor. Laurie and Mike vowed when they first married for better or for worse, in sickness and in health, and Mike has stuck by Laurie's side with every step of her journey with kidney failure.
NxStage Medical Up 19.3% Since SmarTrend Uptrend Call (NXTM)
Comtex SmarTrend(R) - Tue Feb 18, 5:12PM CST
SmarTrend identified an Uptrend for NxStage Medical (NASDAQ:NXTM) on January 9th, 2014 at $11.37. In approximately 1 month, NxStage Medical has returned 19.26% as of today's recent price of $13.56.
Students with Attention-Related Learning Challenges Significantly Increase Academic Performance using Digital Learning Tool in Atentiv School-Based Study
PR Newswire - Fri Feb 14, 7:17AM CST
Children with attention-related learning challenges can improve their academic performance and ability to complete school work at home and in school with the help of a new personalized digital learning tool, it was announced today at the Learning & The Brain conference unfolding in San Francisco where more than 1,000 educators, psychologists and neuroscientists are gathered. The study data were presented by Dr. Ned Hallowell, a child psychiatrist and author of numerous books on attention disorders, including "Driven to Distraction."
NxStage Medical Shares Up 12.1% Since SmarTrend's Buy Recommendation (NXTM)
Comtex SmarTrend(R) - Mon Feb 10, 9:29AM CST
SmarTrend identified an Uptrend for NxStage Medical (NASDAQ:NXTM) on January 9th, 2014 at $11.37. In approximately 1 month, NxStage Medical has returned 12.14% as of today's recent price of $12.75.
NxStage Medical Launches NxStage Plus One at 2014 Annual Dialysis Conference
PR Newswire - Thu Feb 06, 3:02PM CST
NxStage Medical Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced from the Annual Dialysis Conference (ADC) in Atlanta, Georgia (booth #411) the introduction of a new patient outreach campaign, NxStage Plus One. This campaign aims to increase awareness of home hemodialysis with the NxStage® System One(TM) through a series of activities and events focused on encouraging NxStage patients to share their experiences with other end stage renal disease (ESRD) patients. The campaign is designed to bring existing and potential ESRD patients together based on the premise that one-to-one communication is the most compelling way to learn about the benefits of home hemodialysis and support one another in coping with their chronic disease.
NxStage Medical Has Returned 13.9% Since SmarTrend Recommendation (NXTM)
Comtex SmarTrend(R) - Fri Jan 31, 5:15PM CST
SmarTrend identified an Uptrend for NxStage Medical (NASDAQ:NXTM) on January 9th, 2014 at $11.37. In approximately 3 weeks, NxStage Medical has returned 13.90% as of today's recent price of $12.95.
Salt River Project Selects Landis+Gyr for Complete Infrastructure Upgrade
PR Newswire - Tue Jan 28, 8:00AM CST
Salt River Project (SRP) has signed a long-term agreement with Landis+Gyr to update and expand its advanced metering and prepay technology in a phased, 10-year installation across their service territory.
NxStage® to Report Fourth Quarter and Full Year 2013 Financial Results
PR Newswire - Tue Jan 21, 7:24AM CST
NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced plans to release its financial results for the fourth quarter and full year ended December 31, 2013, on Thursday, February 27, 2014, before the opening of the financial markets.
3 Stocks Spiking on Big Volume
at The Street - Tue Jan 14, 1:20PM CST
Unusual volume can signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.
NxStage Increases Revenue Guidance for Fourth Quarter and Full-Year 2013
PR Newswire - Mon Jan 13, 3:05PM CST
NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today increased its revenue guidance for the fourth quarter and fiscal year ended December 31, 2013.
Global and Chinese Hemodialysis Machine Industry Report 2014
M2 - Fri Jan 10, 4:53AM CST
Research and Markets (http://www.researchandmarkets.com/research/q99rd5/global_and) has announced the addition of the "Global and Chinese Hemodialysis Machine Industry Report 2014" report to their offering. The Global and Chinese Hemodialysis Machine Industry Report 2014 is a professional and in-depth study on the current state of the global hemodialysis machine industry with a focus on the Chinese situation. The report first provides a basic overview of the industry including classification, definitions, applications, working principles and industry chain structure. Manufacturing process and cost structures are also offered for the industry. Productions, supply, sales, demand, market status and forecast statistics are provided as well as a look at operation situation analysis. The study focuses on eleven international and three Chinese key industry players including information such as production, market share, demand supply and shortage, production price, cost, profit, production, value profit, margins, etc. Upstream disposables product research is carried out covering Dialyzer, Bloodline, Puncture Needle, Hemodialysis Concentrates and other disposable materials. Industry distribution channels and investment environments are assessed. Finally the feasibility of a new 2000 sets/year hemodialysis machine investment project is analyzed and overall research conclusions reached. With 161 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. Key Topics Covered: Hemodialysis Machine Industry Overview Hemodialysis Machine Manufacturing Process and Cost Structure Hemodialysis Machine Productions Supply Sales Demand Market Status and Forecast 2013 China Hemodialysis Machine Industry Operation Situation Analysis 2012 Global Hemodialysis Machine Industry Operation Situation Analysis International Hemodialysis Machine Manufacturers China Hemodialysis Machine Manufacturers Hemodialysis Machine Upstream Disposables Product Research Hemodialysis Machine Industry Distribution Channels Analysis Hemodialysis Machine Project Industry Environment and Investment Environment Hemodialysis Machine Project Feasibility Analysis Hemodialysis Machine Industry Research Conclusions Tables and Figures Companies Mentioned - Asahi Kasei (Japan) - B.Braun (Germany) - Baxter (USA) - Bellco (Italy) - Fresenius Medical Care (Germany) - Gambro (Sweden) - JMS (Japan) - Nikkiso (Japan) - Nipro (Japan) - NxStage Medical (USA) - Toray (Japan) For more information visit http://www.researchandmarkets.com/research/q99rd5/global_and About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Uptrend Call Working As NxStage Medical Stock Rises 21.8% (NXTM)
Comtex SmarTrend(R) - Wed Mar 12, 11:06AM CDT
SmarTrend identified an Uptrend for NxStage Medical (NASDAQ:NXTM) on January 9th, 2014 at $11.37. In approximately 2 months, NxStage Medical has returned 21.81% as of today's recent price of $13.85.
Downgrade Alert for NxStage Medical (NXTM)
Comtex SmarTrend(R) - Tue Mar 11, 6:58AM CDT
NxStage Medical (NASDAQ:NXTM) was downgraded from Market Perform to Underperform at Wells Fargo today. The stock closed yesterday at $14.66 on volume of 1.3 million shares, above average daily volume of 497,000. In the past 52 weeks, NxStage Medical share prices have been bracketed by a low of $8.77 and a high of $15.00 and closed yesterday at $14.66, 67% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 2.2% while the 200-day MA has remained constant.
US Market for Dialysis Equipment and Concentrates
M2 - Thu Mar 06, 3:09AM CST
Research and Markets (http://www.researchandmarkets.com/research/npv4t6/u_s_market_for) has announced the addition of the "U.S. Market for Dialysis Equipment and Concentrates" report to their offering. The Total Dialysis Device And Concentrates Market Will Grow To A Value Of Almost $2 Billion By 2020 The total dialysis device and concentrates market includes the markets for hemodialysis machines, dialysis catheters, dialysis concentrates, dialyzers, dialyzer reprocessing machines, bloodlines, AV fistula needles, AV grafts, declotting devices, guidewires, introducer sheaths and water treatment systems. The market will grow as a result of increased patient populations. The patient populations of traditional incenter hemodialysis, home hemodialysis (HHD) and peritoneal dialysis are expected to grow over the forecast period. There will also be strong growth in the dry concentrates and heat disinfectant water treatment system market. Scope of the Report - Competitor Analysis - Identified Strategic Opportunities - Market Overview by Segment - Trend Analysis by Segment - Market Drivers & Limiters - Mergers & Acquisitions - Customer Feedback & Market Monitoring Reasons To Buy This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on a 'ground up' approach, which includes primary and secondary research methods. This report forecasts the development of the US market up to 2020. Key Topics Covered - Executive Summary - Research Methodology - US Dialysis Device And Concentrates Market - Hemodialysis Machine Market - Dialysis Catheter Market - Dialysis Concentrates Market - Dialyzer Market - Dialyzer Reprocessing Machine Market - Hemodialysis Bloodline And Tubing Set Market - Av Fistula Needle Market - Av Access Graft Market - Declotting Device Market - Introducer Sheath And Guidewire Market - Water Treatment System Market Companies Mentioned - AmeriWater - AngioDynamics - Argon Medical - Asahi Kasei Medical - B. Braun - Baxter - C. R. Bard - Cook Medical - Cordis - Covidien - Edwards Lifesciences - Fresenius - Gambro - Kawasumi Laboratories - LeMaitre - MAKY - MEDRAD - Mar Cor - Medcomp - Medisystems (NxStage Medical) - Medivators - NxStage Medical - Rockwell - Teleflex Medical - Terumo, - Vascular - W. L. Gore For more information visit http://www.researchandmarkets.com/research/np...market_for About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
Shares of NXTM Up 25.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Mar 05, 9:41AM CST
SmarTrend identified an Uptrend for NxStage Medical (NASDAQ:NXTM) on January 9th, 2014 at $11.37. In approximately 2 months, NxStage Medical has returned 25.95% as of today's recent price of $14.32.
U.S. Market for Dialysis Equipment and Concentrates (Executive Summary)
M2 - Fri Feb 28, 10:28AM CST
Research and Markets (http://www.researchandmarkets.com/research/cbwzlh/u_s_market_for) has announced the addition of the U.S. Market for Dialysis Equipment and Concentrates (Executive Summary) report to their offering. This executive summary relates to the report U.S. Market for Dialysis Equipment and Concentrates. The total dialysis device and concentrates market will grow to a value of almost $2 billion over the forecast period. The total dialysis device and concentrates market includes the markets for hemodialysis machines, dialysis catheters, dialysis concentrates, dialyzers, dialyzer reprocessing machines, bloodlines, AV fistula needles, AV grafts, declotting devices, guidewires, introducer sheaths and water treatment systems. The market will grow as a result of increased patient populations. The patient populations of traditional incenter hemodialysis, home hemodialysis (HHD) and peritoneal dialysis are expected to grow over the forecast period. There will also be strong growth in the dry concentrates and heat disinfectant water treatment system market. This report pertains to a forecast period of 10 years (2010 - 2020) for the U.S. market. Scope of the Report - Competitor Analysis - Identified Strategic Opportunities - Market Overview by Segment - Trend Analysis by Segment - Market Drivers & Limiters - Mergers & Acquisitions - Customer Feedback & Market Monitoring Main Segments Included - U.S. Dialysis Device and Concentrates Market - Hemodialysis Machine Market - Dialysis Catheter Market - Dialysis Concentrates Market - Dialyzer Market - Dialyzer Reprocessing Machine Market - Hemodialysis Bloodline and Tubing Set Market - AV Fistula Needle Market - AV Access Graft Market - Declotting Device Market - Introducer Sheath and Guidewire Market - Water Treatment System Market Reasons To Buy This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on a 'ground up' approach, which includes primary and secondary research methods. * Please note this is an executive summary only. The full report is available for purchase by following the link below. Key Topics Covered: 1. Executive Summary 1.1 U.S. Dialysis Device And Concentrates Market 1.2 Hemodialysis Machine Market 1.3 Dialysis Catheter Market 1.4 Dialysis Concentrates Market 1.5 Dialyzer Market 1.6 Dialyzer Reprocessing Machine Market 1.7 Hemodialysis Bloodline And Tubing Set Market 1.8 Av Fistula Needle Market 1.9 Av Access Graft Market 1.10 Declotting Device Market 1.11 Introducer Sheath And Guidewire Market 1.12 Water Treatment System Market 1.13 Competitive Analysis Companies Mentioned: - AmeriWater - AngioDynamics - Argon Medical - Asahi Kasei Medical - B. Braun - Baxter - C. R. Bard - Cook Medical - Cordis - Covidien - Edwards Lifesciences - Fresenius - Gambro - Kawasumi Laboratories - LeMaitre - MAKY - MEDRAD - Mar Cor - Medcomp - Medisystems (NxStage Medical) - Medivators - NxStage Medical - Rockwell - Teleflex Medical - Terumo, - Vascular - W. L. Gore For more information visit http://www.researchandmarkets.com/research/cb...market_for About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
NxStage Reports Record Fourth Quarter and Full-Year 2013 Financial Results
PR Newswire - Thu Feb 27, 6:31AM CST
NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today reported record financial results for the three and twelve months ended December 31, 2013, that include revenue slightly above its recent guidance.
NxStage Medical Up 20.2% Since SmarTrend Uptrend Call (NXTM)
Comtex SmarTrend(R) - Wed Feb 26, 9:18AM CST
SmarTrend identified an Uptrend for NxStage Medical (NASDAQ:NXTM) on January 9th, 2014 at $11.37. In approximately 2 months, NxStage Medical has returned 20.23% as of today's recent price of $13.67.
BrainStorm Receives Additional $600,000 Non-Dilutive Grant From Israel's Office of the Chief Scientist
Marketwire - Tue Feb 25, 8:15AM CST
BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that BrainStorm Cell Therapeutics Ltd. was awarded an additional non-dilutive grant from Israel's Office of the Chief Scientist (OCS) for the year 2014 in the amount of $600,000. The grant is intended to support BrainStorm's clinical development for its innovative stem cell therapy candidate NurOwn(TM).
Former NxStage Patient Celebrates Life Milestones
PR Newswire - Mon Feb 24, 7:00AM CST
NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, is proud to celebrate with former patient Laurie and her husband/care partner Mike two significant life milestones: their 30 year wedding anniversary and Laurie's second kidney transplant. For the couple, more frequent home hemodialysis (HHD) with the NxStage® System One(TM) proved to be a good personal fit for them. The convenience and flexibility of the therapy not only helped them stay focused on their lifestyle, but also gave them the opportunity to focus their collective energy on finding a second kidney donor. Laurie and Mike vowed when they first married for better or for worse, in sickness and in health, and Mike has stuck by Laurie's side with every step of her journey with kidney failure.
NxStage Medical Up 19.3% Since SmarTrend Uptrend Call (NXTM)
Comtex SmarTrend(R) - Tue Feb 18, 5:12PM CST
SmarTrend identified an Uptrend for NxStage Medical (NASDAQ:NXTM) on January 9th, 2014 at $11.37. In approximately 1 month, NxStage Medical has returned 19.26% as of today's recent price of $13.56.
Students with Attention-Related Learning Challenges Significantly Increase Academic Performance using Digital Learning Tool in Atentiv School-Based Study
PR Newswire - Fri Feb 14, 7:17AM CST
Children with attention-related learning challenges can improve their academic performance and ability to complete school work at home and in school with the help of a new personalized digital learning tool, it was announced today at the Learning & The Brain conference unfolding in San Francisco where more than 1,000 educators, psychologists and neuroscientists are gathered. The study data were presented by Dr. Ned Hallowell, a child psychiatrist and author of numerous books on attention disorders, including "Driven to Distraction."
NxStage Medical Shares Up 12.1% Since SmarTrend's Buy Recommendation (NXTM)
Comtex SmarTrend(R) - Mon Feb 10, 9:29AM CST
SmarTrend identified an Uptrend for NxStage Medical (NASDAQ:NXTM) on January 9th, 2014 at $11.37. In approximately 1 month, NxStage Medical has returned 12.14% as of today's recent price of $12.75.
NxStage Medical Launches NxStage Plus One at 2014 Annual Dialysis Conference
PR Newswire - Thu Feb 06, 3:02PM CST
NxStage Medical Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced from the Annual Dialysis Conference (ADC) in Atlanta, Georgia (booth #411) the introduction of a new patient outreach campaign, NxStage Plus One. This campaign aims to increase awareness of home hemodialysis with the NxStage® System One(TM) through a series of activities and events focused on encouraging NxStage patients to share their experiences with other end stage renal disease (ESRD) patients. The campaign is designed to bring existing and potential ESRD patients together based on the premise that one-to-one communication is the most compelling way to learn about the benefits of home hemodialysis and support one another in coping with their chronic disease.
NxStage Medical Has Returned 13.9% Since SmarTrend Recommendation (NXTM)
Comtex SmarTrend(R) - Fri Jan 31, 5:15PM CST
SmarTrend identified an Uptrend for NxStage Medical (NASDAQ:NXTM) on January 9th, 2014 at $11.37. In approximately 3 weeks, NxStage Medical has returned 13.90% as of today's recent price of $12.95.
Salt River Project Selects Landis+Gyr for Complete Infrastructure Upgrade
PR Newswire - Tue Jan 28, 8:00AM CST
Salt River Project (SRP) has signed a long-term agreement with Landis+Gyr to update and expand its advanced metering and prepay technology in a phased, 10-year installation across their service territory.
NxStage® to Report Fourth Quarter and Full Year 2013 Financial Results
PR Newswire - Tue Jan 21, 7:24AM CST
NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced plans to release its financial results for the fourth quarter and full year ended December 31, 2013, on Thursday, February 27, 2014, before the opening of the financial markets.
3 Stocks Spiking on Big Volume
at The Street - Tue Jan 14, 1:20PM CST
Unusual volume can signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.
NxStage Increases Revenue Guidance for Fourth Quarter and Full-Year 2013
PR Newswire - Mon Jan 13, 3:05PM CST
NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today increased its revenue guidance for the fourth quarter and fiscal year ended December 31, 2013.
Global and Chinese Hemodialysis Machine Industry Report 2014
M2 - Fri Jan 10, 4:53AM CST
Research and Markets (http://www.researchandmarkets.com/research/q99rd5/global_and) has announced the addition of the "Global and Chinese Hemodialysis Machine Industry Report 2014" report to their offering. The Global and Chinese Hemodialysis Machine Industry Report 2014 is a professional and in-depth study on the current state of the global hemodialysis machine industry with a focus on the Chinese situation. The report first provides a basic overview of the industry including classification, definitions, applications, working principles and industry chain structure. Manufacturing process and cost structures are also offered for the industry. Productions, supply, sales, demand, market status and forecast statistics are provided as well as a look at operation situation analysis. The study focuses on eleven international and three Chinese key industry players including information such as production, market share, demand supply and shortage, production price, cost, profit, production, value profit, margins, etc. Upstream disposables product research is carried out covering Dialyzer, Bloodline, Puncture Needle, Hemodialysis Concentrates and other disposable materials. Industry distribution channels and investment environments are assessed. Finally the feasibility of a new 2000 sets/year hemodialysis machine investment project is analyzed and overall research conclusions reached. With 161 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. Key Topics Covered: Hemodialysis Machine Industry Overview Hemodialysis Machine Manufacturing Process and Cost Structure Hemodialysis Machine Productions Supply Sales Demand Market Status and Forecast 2013 China Hemodialysis Machine Industry Operation Situation Analysis 2012 Global Hemodialysis Machine Industry Operation Situation Analysis International Hemodialysis Machine Manufacturers China Hemodialysis Machine Manufacturers Hemodialysis Machine Upstream Disposables Product Research Hemodialysis Machine Industry Distribution Channels Analysis Hemodialysis Machine Project Industry Environment and Investment Environment Hemodialysis Machine Project Feasibility Analysis Hemodialysis Machine Industry Research Conclusions Tables and Figures Companies Mentioned - Asahi Kasei (Japan) - B.Braun (Germany) - Baxter (USA) - Bellco (Italy) - Fresenius Medical Care (Germany) - Gambro (Sweden) - JMS (Japan) - Nikkiso (Japan) - Nipro (Japan) - NxStage Medical (USA) - Toray (Japan) For more information visit http://www.researchandmarkets.com/research/q99rd5/global_and About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
